150 related articles for article (PubMed ID: 30938275)
1. Clinical significance of myositis-specific autoantibodies.
Nakashima R
Immunol Med; 2018 Sep; 41(3):103-112. PubMed ID: 30938275
[TBL] [Abstract][Full Text] [Related]
2. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
Lan JL; Chang SH; Tsay GJ; Chen DY; Chao YH; Li JP
BMC Immunol; 2023 Sep; 24(1):33. PubMed ID: 37752437
[TBL] [Abstract][Full Text] [Related]
3. Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies.
Ueda-Hayakawa I; Tonomura K; Maekawa A; Kaneda E; Arase N; Fujimoto M
J Dermatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 36890683
[TBL] [Abstract][Full Text] [Related]
4. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
5. Murine models of idiopathic inflammatory myopathies.
Okiyama N; Konishi R; Ichimura Y
J Dermatol; 2024 Feb; ():. PubMed ID: 38321631
[TBL] [Abstract][Full Text] [Related]
6. Myositis-Related Interstitial Lung Disease: A Respiratory Physician's Point of View.
Waseda Y
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34200737
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and prognosis of idiopathic inflammatory myopathies with coexistent multiple myositis-specific antibodies.
Liang X; Wu J; Ren H; Li M; Huang C; Guo JG; Li D; Li J; Zhu J
Clin Exp Rheumatol; 2024 May; ():. PubMed ID: 38819961
[TBL] [Abstract][Full Text] [Related]
8. Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis.
Kimura M; Aizawa A; Kudou R; Rikitake Y; Iwao C; Rikitake M; Iwao K; Kariya Y; Kawaguchi T; Matsuda M; Miyauchi S; Takajo I; Umekita K
Clin Exp Rheumatol; 2024 Feb; 42(2):321-328. PubMed ID: 37497714
[TBL] [Abstract][Full Text] [Related]
9. Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease.
Hannah JR; Lawrence A; Martinovic J; Naqvi M; Chua F; Kouranos V; Ali SS; Stock C; Owens C; Devaraj A; Pollard L; Agarwal S; Atienza-Mateo B; González-Gay MA; Patel A; West A; Tinsley K; Robbie H; Lams B; Wells AU; Norton S; Galloway J; Renzoni EA; Gordon PA
Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38039151
[TBL] [Abstract][Full Text] [Related]
10. Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population.
Mecoli CA; Igusa T; Chen M; Wang X; Albayda J; Paik JJ; Tiniakou E; Adler B; Richardson C; Kelly W; Danoff S; Mammen AL; Platz EA; Rosen A; Christopher-Stine L; Casciola-Rosen L; Shah AA
Arthritis Rheumatol; 2023 Apr; 75(4):620-629. PubMed ID: 35878018
[TBL] [Abstract][Full Text] [Related]
11. Analytic and Clinical Validity of Myositis-Specific Antibodies by Line-Blot Immunoassay Is Essential.
Tseng CW; Satoh M; Hasegawa T; Tanaka S; Chen YM
J Clin Rheumatol; 2024 Jan; 30(1):e23-e28. PubMed ID: 37983669
[TBL] [Abstract][Full Text] [Related]
12. In-depth proteomic analysis of juvenile dermatomyositis serum reveals protein expression associated with muscle-specific autoantibodies.
Sato H; Inoue Y; Kawashima Y; Konno R; Ohara O; Kuwana M; Kobayashi N; Takezaki S; Akioka S
Rheumatology (Oxford); 2023 Oct; 62(10):3501-3506. PubMed ID: 37052527
[TBL] [Abstract][Full Text] [Related]
13. What should we expect when two myositis-specific antibodies coexist in a patient.
Zheng Y; Zhao Y; Hao H; Wang Z; Gao F; Zhang W; Yuan Y
Eur J Med Res; 2023 Oct; 28(1):429. PubMed ID: 37828570
[TBL] [Abstract][Full Text] [Related]
14. Association between periungual changes and myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies: A retrospective cohort study.
Ueda-Hayakawa I; Maekawa A; Tonomura K; Kaneda E; Yamazaki Y; Arase N; Fujimoto M
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38704031
[No Abstract] [Full Text] [Related]
15. Progression prediction in idiopathic inflammatory myopathy-associated interstitial lung disease: a combination of initial high attenuation areas and anti-melanoma differentiation-associated gene 5-positive.
Fang X; Zou L; Zhao H; Liu B
Clin Exp Rheumatol; 2024 Feb; 42(2):253-261. PubMed ID: 38293996
[TBL] [Abstract][Full Text] [Related]
16. Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy.
Beam MJ; Montgomery A; Anastasiou C; Schmajuk G
Clin Rheumatol; 2023 Nov; 42(11):3043-3047. PubMed ID: 37542130
[TBL] [Abstract][Full Text] [Related]
17. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort.
Loganathan A; Gupta L; Rudge A; Lu H; Bowler E; McMorrow F; Naveen R; Anuja AK; Agarwal V; McHugh N; Tansley S
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38479813
[TBL] [Abstract][Full Text] [Related]
18. Anti-PL-7, anti-Ro/SSA, anti-Mi-2, and anti-TIF1-γ correlate with specific patterns of histopathologic features in dermatomyositis: An analysis of 39 skin biopsy specimens from 25 patients.
Bennett R; Bradley K; Stevanovic M; McFadden JR; Chaudhari AS; Ramos-Rodriguez AJ; Yan S; Momtahen S; LeBlanc RE; Cloutier JM; Salem I; Grand DG; Hodson EL; Sriharan A
J Cutan Pathol; 2024 Apr; 51(4):317-326. PubMed ID: 38158735
[TBL] [Abstract][Full Text] [Related]
19. Using autoantibody signatures to define cancer risk in dermatomyositis.
Turnier JL; Kahlenberg JM
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 35040442
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Reclassification of Idiopathic Inflammatory Myopathy to Match the Serological Results of Myositis-Specific Antibodies.
Park YE; Kim DS; Kang M; Shin JH
J Clin Neurol; 2024 Jan; 20(1):67-77. PubMed ID: 38179634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
